Full Text
Type 2 diabetes mellitus is associated with progressive microvascular damage that commonly affects the retina and kidneys. These organs share similar microcirculatory characteristics, making them highly susceptible to chronic hyperglycemia and endothelial dysfunction. Nephroretinal syndrome reflects the parallel involvement of these systems, where retinal changes mirror renal impairment. Early diagnosis is essential to prevent irreversible damage; however, conventional methods often detect complications at advanced stages. Retinal imaging techniques such as OCT and OCTA provide high-resolution visualization of both structural and vascular components, enabling identification of subtle abnormalities that may serve as early biomarkers of systemic disease. The retina offers a unique, non-invasive window for assessing microvascular health, and its evaluation may provide valuable insight into the progression of diabetic nephropathy. This study aims to explore the relationship between retinal biomarkers and renal function, emphasizing their role in early diagnosis and risk stratification. Chronic hyperglycemia leads to progressive microvascular damage affecting multiple organ systems, with the retina and kidneys being among the most vulnerable due to their dense capillary networks and high metabolic demands. The concept of nephroretinal involvement highlights the parallel progression of pathological processes in these organs, where structural and functional alterations occur simultaneously. Traditional diagnostic approaches often fail to detect early-stage changes, limiting the opportunity for preventive intervention. Recent advances in imaging technologies have enabled detailed visualization of retinal microarchitecture and circulation, allowing identification of subtle abnormalities that may serve as early indicators of systemic dysfunction. The retina provides a unique opportunity to observe these processes directly, offering valuable insights into the status of the microvascular system as a whole. Understanding the relationship between retinal biomarkers and renal function is essential for improving early diagnostic strategies and optimizing patient management.
2. Materials and Methods
A cross-sectional study was conducted involving 130 patients with type 2 diabetes mellitus, categorized into groups based on the stage of renal impairment, along with 40 healthy controls. All participants underwent comprehensive ophthalmological examination, including visual acuity assessment and fundus evaluation. Structural retinal analysis was performed using spectral-domain OCT to measure central macular thickness, ganglion cell layer thickness, and retinal nerve fiber layer parameters. OCT angiography was used to assess microvascular features, including vessel density in superficial and deep capillary plexuses, foveal avascular zone (FAZ) area, and perfusion density indices. Renal function was evaluated using eGFR calculations and urinary albumin excretion levels. Statistical analysis was performed to determine correlations between retinal biomarkers and renal parameters, with significance set at p<0.065
The study revealed significant associations between retinal biomarkers and renal function status. Patients with early-stage renal impairment exhibited subtle reductions in vessel density and mild enlargement of the foveal avascular zone, even in the absence of clinically evident retinopathy. As renal dysfunction progressed, these changes became more pronounced, with marked decreases in capillary perfusion and thinning of inner retinal layers. OCT measurements demonstrated a gradual reduction in ganglion cell complex thickness, indicating early neurodegenerative processes. Strong correlations were observed between decreasing eGFR values and worsening OCT/OCTA parameters, including increased FAZ area and reduced vascular density. Additionally, patients with higher levels of albuminuria showed greater disruption of microvascular integrity. These findings confirm that retinal biomarkers reflect the severity of systemic microvascular damage and can serve as early indicators of nephroretinal involvement. The analysis demonstrated a consistent relationship between alterations in retinal parameters and the degree of renal impairment. Initial stages were characterized by mild reductions in microvascular perfusion and minimal structural changes, while more advanced conditions showed significant decreases in capillary density and pronounced thinning of neural layers. Enlargement of avascular regions and reduced perfusion indices were observed in parallel with declining renal function indicators. Functional evaluation revealed gradual deterioration in visual performance corresponding to these structural and vascular changes. Statistical findings confirmed strong correlations between quantitative retinal measurements and renal parameters, indicating that progressive systemic impairment is reflected in ocular microcirculation. These results support the use of retinal biomarkers as reliable indicators of early systemic microvascular damage.
The results highlight the clinical significance of retinal biomarkers in the early detection of nephroretinal syndrome in patients with type 2 diabetes mellitus. The observed correlation between OCT/OCTA parameters and renal function supports the concept of shared pathophysiological mechanisms underlying microvascular complications. Chronic hyperglycemia leads to endothelial dysfunction, capillary dropout, and impaired autoregulation, affecting both retinal and renal tissues. The ability of OCTA to detect microvascular changes before the onset of visible retinopathy provides a valuable advantage in early diagnosis. Furthermore, structural changes identified by OCT, such as thinning of neural layers, reflect ongoing neurodegeneration that parallels vascular impairment. These findings suggest that retinal imaging can be integrated into routine clinical assessment to improve risk stratification and guide therapeutic decisions. Early identification of high-risk patients allows for timely intervention, potentially slowing disease progression and reducing complications. The observed associations emphasize the shared pathophysiological mechanisms underlying microvascular complications in diabetes. Persistent metabolic imbalance contributes to endothelial dysfunction, impaired autoregulation, and capillary loss, affecting both retinal and renal tissues. The retina’s accessibility and sensitivity make it an effective site for early detection of these changes. Advanced imaging techniques allow for detailed assessment of both structural integrity and vascular function, providing comprehensive information about disease progression. The strong correlation between ocular and renal findings suggests that retinal evaluation can serve as a surrogate marker for systemic microvascular health. This approach enhances the ability to identify high-risk individuals at an early stage and supports the implementation of targeted therapeutic strategies. The integration of such diagnostic tools into routine clinical practice may significantly improve outcomes by enabling earlier and more precise intervention.
Retinal biomarkers obtained through OCT and OCT angiography play a crucial role in the early diagnosis of nephroretinal syndrome in type 2 diabetes mellitus. Their strong correlation with renal function parameters underscores their value as non-invasive indicators of systemic microvascular health. Early detection of structural and vascular changes enables more accurate monitoring and timely intervention, contributing to improved patient outcomes. Incorporating retinal imaging into routine evaluation of diabetic patients may enhance the management of both retinal and renal complications. Continued research is needed to refine biomarker thresholds and optimize their clinical application in predictive and preventive strategies. Retinal biomarkers play a critical role in the early identification of nephroretinal involvement in type 2 diabetes mellitus. Their close association with renal function highlights their value as non-invasive indicators of systemic microvascular status. Early detection of structural and circulatory abnormalities allows for improved monitoring and timely therapeutic intervention, reducing the risk of progression to advanced complications. Incorporating retinal imaging into standard diagnostic protocols offers a promising strategy for enhancing patient care and preserving both visual and systemic health.
1. Antonetti DA, Klein R, Gardner TW. Diabetic retinopathy. N Engl J Med. 2012;366:1227–1239.
2. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–136.
3. De Carlo TE, et al. OCT angiography in diabetic retinopathy. Curr Opin Ophthalmol. 2016;27(3):210–216.
4. Stitt AW, et al. Advances in diabetic retinopathy. Nat Rev Endocrinol. 2016;12:76–89.
5. Ting DSW, et al. Diabetic microvascular complications. Nat Rev Dis Primers. 2016;2:16012.
6. Klein R, Klein BEK. Epidemiology of diabetic retinopathy. Diabetes Care. 1995;18:1407–1414.
7. Simó R, Hernández C. Neurodegeneration in diabetic retinopathy. Diabetologia. 2014;57:122–131.
8. Chua J, et al. OCTA biomarkers in systemic disease. Prog Retin Eye Res. 2019;73:100802.
9. Hee MR, et al. Optical coherence tomography. Arch Ophthalmol. 1995;113:325–332.
10. Wilkinson CP, et al. Clinical diabetic retinopathy severity scale. Ophthalmology. 2003;110:1677–1682.